Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 66.08
Day High 67.54
Open:66.43
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Gilead Sciences COMPASS Initiative(TM) Awards Over $2.3M to 40 Organizations Fighting HIV in the South
- PR Newswire - Thu Dec 5, 9:00AM CST
PR Newswire - CMTX
Thu Dec 5, 9:00AM CST
Today, Emory University Rollins School of Public Health, Southern AIDS Coalition, and the University of Houston Graduate College of Social Work announced 40 organizations that will receive a total of $2,309,592 to combat the spread of HIV in the South and support people living with HIV. The three organizations are the Coordinating Centers of Gilead Sciences' COMPASS Initiative (COMPASS), which identified grantees engaged in community-driven solutions that are improving the health and well-being of those impacted by HIV in the South.
National AIDS Memorial Welcomes First Panels of the AIDS Quilt Home to San Francisco During World AIDS Day Observances; Honors Leaders in the HIV-AIDS Movement
- GlobeNewswire - Sat Nov 30, 10:32AM CST
GlobeNewswire - CMTX
Sat Nov 30, 10:32AM CST
This <b>World AIDS Day</b>, more than 1,500 people are expected to gather in the heart of the National AIDS Memorial to welcome home the first group of panels of the AIDS Memorial Quilt (the Quilt) back to San Francisco and honor leaders who have helped bring together the vast voices of the epidemic with profound courage, unrelenting hope and unity of humankind.
National AIDS Memorial Receives $2.4 Million Donation From Gilead Sciences to Support the AIDS Memorial Quilt as It Moves Home to San Francisco
- BusinessWire - Wed Nov 27, 1:16PM CST
BusinessWire - CMTX
Wed Nov 27, 1:16PM CST
Today, the National AIDS Memorial and Gilead Sciences, Inc. (Nasdaq: GILD) announced a $2.4 million donation from Gilead to support The AIDS Memorial Quilt (The Quilt), its public education programs and its relocation to San Francisco under the stewardship of the National AIDS Memorial.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 62.38 +7.53% increase
on 11/14/19
Period Open:65.41
Price movement based on the high, low and last over the given period.
67.65 -0.84% decrease
on 11/26/19
+1.67 (+2.55%) increase
since 11/06/19
3-Month 60.89 +10.17% increase
on 10/03/19
Period Open:64.82
Price movement based on the high, low and last over the given period.
68.16 -1.58% decrease
on 09/11/19
+2.26 (+3.49%) increase
since 09/06/19
52-Week 60.32 +11.21% increase
on 12/26/18
Period Open:70.19
Price movement based on the high, low and last over the given period.
70.50 -4.85% decrease
on 02/01/19
-3.11 (-4.43%) decrease
since 12/06/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies